Cell viability assay also showed thatp300 HAT inhibitor (C646) attenuated the promoting effect of XRCC5 on colon cancer cell viability, which implicates that acetylation by p300 is essential for XRCC5 to promote colon cancer cell proliferation. Here, XRCC5 is linked to malignant colon neoplasm.